Metabolic dysfunction–associated steatotic liver disease (MASLD) is the name adopted in 2023 for the condition previously known as non-alcoholic fatty...
129 KB (14,440 words) - 13:23, 23 May 2024
cirrhosis, liver cancer, and esophageal varices. The main subtypes of fatty liver disease are metabolic dysfunction–associated steatotic liver disease (MASLD...
38 KB (3,896 words) - 13:25, 18 May 2024
cardiovascular disease. Chronically elevated serum triglyceride levels are a component of metabolic syndrome and metabolic dysfunction-associated steatotic liver disease...
15 KB (1,429 words) - 11:56, 27 May 2024
high-density lipoprotein (HDL). Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. In the U.S....
59 KB (6,651 words) - 02:53, 24 May 2024
Steatohepatitis (category Diseases of liver)
constitute fatty liver changes. There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (previously...
6 KB (467 words) - 12:02, 13 March 2024
Semaglutide (category Experimental drugs developed for non-alcoholic fatty liver disease)
lowering liver enzymes (transaminitis) and improving certain radiologically observed features of metabolic dysfunction–associated steatotic liver disease. French...
66 KB (5,418 words) - 18:14, 27 May 2024
SUCNR1 (section Liver diseases)
Sanyal AJ (September 2023). "Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient...
73 KB (9,208 words) - 02:57, 24 May 2024